These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11096408)

  • 1. Basics of designing a clinical trial: part II.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):293-5. PubMed ID: 11096408
    [No Abstract]   [Full Text] [Related]  

  • 2. Basics of designing a clinical trial: part I.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Sep; 27(5):257-9. PubMed ID: 10999963
    [No Abstract]   [Full Text] [Related]  

  • 3. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 4. Planning the analysis of a breast cancer prevention trial.
    Moon TE
    Prev Med; 1991 Jan; 20(1):109-18. PubMed ID: 2008420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 6. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 8. The delayed-start study in Parkinson disease: can't satisfy everyone.
    Olanow CW; Rascol O
    Neurology; 2010 Apr; 74(14):1149-50. PubMed ID: 20368635
    [No Abstract]   [Full Text] [Related]  

  • 9. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ISAT trial.
    Sellar R; Whittle I
    Lancet; 2003 Feb; 361(9355):432-3; author reply 433. PubMed ID: 12573406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interim analyses].
    Kramar A; Paoletti X
    Bull Cancer; 2007 Nov; 94(11):965-74. PubMed ID: 18055314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of health and statistics.
    Church TR
    J Natl Cancer Inst; 2008 Apr; 100(7):452-3. PubMed ID: 18364500
    [No Abstract]   [Full Text] [Related]  

  • 14. A psychotherapeutic context for clinical trials is promising, but manualization is not.
    Klein DF
    Arch Gen Psychiatry; 1997 Oct; 54(10):929-30. PubMed ID: 9337773
    [No Abstract]   [Full Text] [Related]  

  • 15. Education section - designing a "placebo" to help define the intervention.
    J Evid Based Med; 2011 Nov; 4(4):261-2. PubMed ID: 23672759
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplicity in oncology randomised controlled trials: a threat to medical evidence?
    Prasad V; Booth CM
    Lancet Oncol; 2019 Dec; 20(12):1638-1640. PubMed ID: 31797779
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 19. Leaving nothing to chance: how to randomize a clinical trial.
    Toltl LJ; Arnold DM
    Transfusion; 2012 Dec; 52(12):2513-5. PubMed ID: 22670887
    [No Abstract]   [Full Text] [Related]  

  • 20. The line of 'no difference' is not engraved in stone: the utility of non-inferiority clinical trials.
    Joshi M; Ananth CV
    BJOG; 2014 Jul; 121(8):920-2. PubMed ID: 24958567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.